Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Saved in:

Bibliographic Details
Published in:	Therapeutic advances in neurological disorders Vol. 14; p. 17562864211020082
Main Authors:	Achiron, Anat, Mandel, Mathilda, Dreyer-Alster, Sapir, Harari, Gil, Magalashvili, David, Sonis, Polina, Dolev, Mark, Menascu, Shay, Flechter, Shlomo, Falb, Rina, Gurevich, Michael
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 2021 SAGE PUBLICATIONS, INC SAGE Publishing
Subjects:	COVID-19 Immune response (humoral) Letter to the Editor Monoclonal antibodies mRNA Multiple sclerosis COVID-19 cladrivine ocrelizumab multiple sclerosis mRNA vaccine finfolimod
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1756-2864 1756-2856 1756-2864
DOI:	10.1177/17562864211020082